Medicina de Emergências
Debate Pró-Con | Transfusão sanguínea pré-hospitalar – deveria ser adotada para traumas em civis?
22 Mar, 2022 | 11:37hInfográfico: Pre-Hospital Blood Transfusion: A Pro-Con Debate – Anesthesia & Analgesia
Conteúdo relacionado: RCT: In patients with trauma-related hemorrhagic shock receiving prehospital care, there was no benefit from resuscitation with blood products compared to 0.9% sodium chloride.
Diretriz | Manejo de anticoagulantes e antiplaquetários durante sangramento gastrintestinal agudo e período periendoscópico.
21 Mar, 2022 | 16:38h
Comentário no Twitter
BREAKING 🔥
Antiplatelets, anticoagulants and #EndoscopyNew CPG & dissemination tool.
An @AmCollegeGastro @CanGastroAssn co-production @AmJGastro and #JCAG@GriLeont @BryanGSauer @NeenaSAbrahamMD @alan_barkun @ThrombosisCan @LorenLaine2 #JenTelfordhttps://t.co/Ijs4jgOkPC pic.twitter.com/uUfN2zj3RS
— Journal of the Canadian Assn of Gastroenterology (@JCanAssnGastro) March 17, 2022
Estudo mostra baixo risco de complicações após colocação de cateter intravenoso ipsilateral em pacientes cirúrgicas de câncer de mama.
21 Mar, 2022 | 16:26hIpsilateral Intravenous Catheter Placement in Breast Cancer Surgery Patients – Anesthesia & Analgesia (link para o resumo – $ para o texto completo)
Comentário no Twitter
🙏🙏🙏 much-needed dogmalysis. I’ve seen situations where folks were afraid to even place a Bp cuff ipsilateral to prior mastectomy. this excessive fear impairs patient care. https://t.co/afjwjjseo7
— 𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊 (@PulmCrit) March 17, 2022
Estudo de coorte | Características e desfechos do infarto agudo do miocárdio tipo 2.
21 Mar, 2022 | 16:05hCharacteristics and Outcomes of Type 2 Myocardial Infarction – JAMA Cardiology (link para o resumo – $ para o texto completo)
Comentários:
Type 2 MI Not Uncommon in the Emergency Department – TCTMD
Type 2 Myocardial Infarction: Clinical Characteristics and Outcomes – American College of Cardiology
Comentário no Twitter
Among patients presenting with acute chest discomfort to the emergency department, tachyarrhythmias and hypertension are responsible for more than two thirds of type 2 myocardial infarction and result in a lower mortality compared to other triggers. https://t.co/ODMCmOjeQO
— JAMA Cardiology (@JAMACardio) March 10, 2022
Estudo randomizado | Contezolida oral vs. linezolida em adultos com infecções cutâneas e de partes moles complicadas.
21 Mar, 2022 | 15:58hA Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections – Journal of Antimicrobial Therapy (link para o resumo – $ para o texto completo)
Comentário no Twitter
Phase III efficacy & safety of oral contezolid Vs linezolid in adults with c.SSTIs
📌Non inferior
📌Interestingly:Contezolid demonstrated significant lower incidence thrombocytopenia (0% Wow vs 2.3%) & leucopenia (0.3% vs 3.4%) than linezolid
📌QIDP https://t.co/wSvxUInnkZ— Antibiotic Steward Bassam Ghanem (@ABsteward) March 11, 2022
Decisão do consenso de especialistas da ACC de 2022 sobre sequelas cardiovasculares de COVID-19 em adultos: miocardite e outros envolvimentos miocárdicos, sequelas pós-agudas da infecção pelo SARS-CoV-2 e volta aos esportes.
17 Mar, 2022 | 13:25hComentários:
ACC Issues Clinical Guidance on CV Consequences of COVID-19 – American College of Cardiology
ACC Releases Guidance on CV Issues With COVID-19 – TCTMD
Pontos principais: 2022 ACC Decision Pathway on Cardiovascular Sequelae of COVID-19
Conteúdos relacionados:
Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.
COVID-19 infections increase risk of heart conditions up to a year later, study finds.
Comentário no Twitter (fio – clique para saber mais)
Access the full ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-acute Sequelae of SARS-CoV-2 Infection, and Return to Play: https://t.co/ph75qZxfpT #JACC @JACCJournals #CardioTwitter (8/8) pic.twitter.com/mpYJic6gem
— American College of Cardiology (@ACCinTouch) March 16, 2022
Evidências Cochrane | Tratamento para COVID-19 moderada a grave.
17 Mar, 2022 | 13:22hTreatments for moderate to severe COVID-19: Cochrane evidence – Evidently Cochrane
Evidências Cochrane | Tratamento para COVID-19 leve.
17 Mar, 2022 | 13:20hTreatments for mild COVID-19: Cochrane evidence – Cochrane Library
Hipertensão maligna: perspectivas atuais e desafios.
17 Mar, 2022 | 13:12hEstudo multicêntrico e aberto sobre acetato de flecainida em solução de inalação oral para conversão aguda de fibrilação atrial sintomática de início recente para ritmo sinusal.
17 Mar, 2022 | 13:11h
Comentário no Twitter
Inhalation of flecainide simply converts many episodes of recent onset atrial fibrillation #AHAJournals #HeartMonthhttps://t.co/vNXx4fKy2u pic.twitter.com/UNGA9DX3qM
— CircEP (@CirculationEP) February 25, 2022